Sloppy Pfizer Booster Clinical Trial Consent Form Provides Way to Exclude Reactions That Require Emergency Care
The Pfizer consent form for a clinical of its booster shot is troubling from a participants and public health persepctive.
Read more...The Pfizer consent form for a clinical of its booster shot is troubling from a participants and public health persepctive.
Read more...Another theory about the apparent decline in UK Covid cases right after Freedom Day.
Read more...Cuomo, like his Team Dem allies, insists the vaccines will allow him to stay the reopening course when Delta is throwing a big money wrench
Read more...If you weren’t worried about Covid, you should be, between rising infections and evidence of CDC incompetence.
Read more...Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...Doubts about the suddenly improved UK Covid case figures.
Read more...Hurbert Horan explains how major airline operators are still engaging in magical thinking.
Read more...The Gates Foundation and the WEF are steamrolling normal UN processes as part of a campaign to discredit sound agroecology practices.
Read more...Documenting yet another way public pensions funds lie to themselves and their many constituencies about their performance.
Read more...Inflation is hitting a few important sectors very hard. The Fed isn’t set up to contend with this problem, but will it try anyhow?
Read more...Cleveland Clinic’s and the CDC Foundation’s unsound Clorox sponsorship confirms that the US has the best medical system that money can buy.
Read more...How Bitcoin hard-core loyalists see the future of their project.
Read more...Tiny Payday Report does the Bureau of Labor Statistics to shame in tracking strikes in 2020. What gives?
Read more...The Covid propagation and vaccine news is not pointing to happy outcomes
Read more...The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
Read more...